Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04700072
Title Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Merck Sharp & Dohme Corp.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | AUS

Facility Status City State Zip Country Details
The Angeles Clinic and Research Institute ( Site 4009) Los Angeles California 90025 United States Details
UCLA Hematology & Oncology ( Site 4004) Los Angeles California 90095 United States Details
Providence Saint John's Health Center ( Site 4010) Santa Monica California 90404 United States Details
University of Colorado, Anschutz Cancer Pavilion ( Site 4012) Aurora Colorado 80045 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ( Site 4022) Baltimore Maryland 21287 United States Details
NYU Clinical Cancer Center ( Site 4002) New York New York 10016 United States Details
Duke Cancer Institute ( Site 4005) Durham North Carolina 27710 United States Details
Martha Morehouse Tower ( Site 4020) Columbus Ohio 43221 United States Details
Inova Schar Cancer Institute ( Site 4011) Fairfax Virginia 22031 United States Details
Calvary Mater Newcastle ( Site 4404) Waratah New South Wales 2298 Australia Details
Melanoma Institute Australia ( Site 4402) Wollstonecraft New South Wales 2065 Australia Details
Hopital La Timone ( Site 4103) Marseille Bouches-du-Rhone 13005 France Details
CHU de Bordeaux- Hopital Saint Andre ( Site 4108) Bordeaux Gironde 33075 France Details
Institut Claudius Regaud ( Site 4105) Toulouse cedex 9 Haute-Garonne 31059 France Details
Gustave Roussy ( Site 4101) Villejuif Ile-de-France 94800 France Details
Centre Hospitalier Lyon Sud ( Site 4102) Pierre Benite Rhone 69495 France Details
A.P.H. Paris, Hopital Saint Louis ( Site 4107) Paris 75010 France Details
HaEmek Medical Center ( Site 4703) Afula 1834111 Israel Details
Rambam Health Care Campus-Oncology ( Site 4704) Haifa 3109601 Israel Details
Hadassah Ein Karem Jerusalem ( Site 4702) Jerusalem 9112001 Israel Details
Rabin Medical Center-Oncology ( Site 4705) Petah-Tikva 4941492 Israel Details
Chaim Sheba Medical Center ( Site 4701) Ramat Gan 5265601 Israel Details
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano ( Site 4399) Milano 20133 Italy Details
Istituto Europeo di Oncologia ( Site 4301) Milano 20141 Italy Details
Istituto Nazionale Tumori Fondazione Pascale ( Site 4302) Napoli 80131 Italy Details
Istituto Oncologico Veneto IRCCS ( Site 4355) Padova 35128 Italy Details
Policlinico Le Scotte - A.O. Senese ( Site 4377) Siena 53100 Italy Details
CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE ( Site 4865) Port Elizabeth Eastern Cape 6055 South Africa Details
LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 4861) Pretoria Gauteng 0181 South Africa Details
Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 4863) Sandton Gauteng 2196 South Africa Details
Cape Town Oncology Trials ( Site 4864) Cape Town Western Cape 7570 South Africa Details
HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Sit Barcelona Cataluna 08036 Spain Details
Hospital Universitario Ramón y Cajal ( Site 4802) Madrid Madrid, Comunidad De 28034 Spain Details
Hôpitaux Universitaires de Genève (HUG)-Oncology ( Site 4603) Genève Geneve 1211 Switzerland Details
CHUV Centre Hospitalier Universitaire Vaudois ( Site 4602) Lausanne Vaud 1011 Switzerland Details
Universitaetsspital Zuerich ( Site 4601) Zurich 8058 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field